share_log

Alliance Global Partners Upgrades Alimera Sciences to Buy, Raises Price Target to $8

Alliance Global Partners Upgrades Alimera Sciences to Buy, Raises Price Target to $8

联盟全球合作伙伴将Alimera Sciences升级为买入,将目标价提高至8美元
Benzinga ·  2023/06/12 08:18

Alliance Global Partners analyst James Molloy upgrades Alimera Sciences (NASDAQ:ALIM) from Neutral to Buy and raises the price target from $4.5 to $8.

联盟全球合作伙伴分析师詹姆斯·莫洛伊将Alimera Sciences(纳斯达克股票代码:ALIM)从中性上调至买入,并将目标股价从4.5美元上调至8美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发